News Roche Holding AG OTC Markets

Equities

RHHBY

US7711951043

Market Closed - OTC Markets Other stock markets 16:00:00 2024-06-25 EDT			5-day change	1st Jan Change
35.57 ^USD	-0.39%		+1.69%	-1.82%

06-25	Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval	MT
06-25	Roche: approval of Ocrevus SC in Europe	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval	06-25	MT
Roche: approval of Ocrevus SC in Europe	06-25	CF
Roche Wins EU Nod for Subcutaneous Formula of Multiple Sclerosis Drug Ocrevus	06-25	MT
Roche's Multiple Sclerosis Injection Gets EU Approval	06-25	DJ
Halozyme Therapeutics, Inc. Announces Roche's OCREVUS SC with ENHANZE Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis	06-25	CI
Roche Announces the European Commission Grants Marketing Authorisation for OCREVUS (Ocrelizumab) Subcutaneous for the Treatment of Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis	06-25	CI
Swiss Market Index in Green as Investors Keep Eye on European Politics	06-24	MT
Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...	06-24
Foreign banks target Switzerland after UBS takeover of Credit Suisse	06-24	RE
ROCHE HOLDINGS AG : Barclays reiterates its Neutral rating	06-24	ZD
Roche: two new units for cobas pro	06-24	CF
Roche: marketing authorization application validated for Elevidys in Europe	06-24	CF
European Medicines Agency Begins Review of Roche's Gene Therapy for Duchenne Muscular Dystrophy	06-24	MT
US FDA approves Roche's drug for a chronic blood disorder	06-21	RE
Nykredit Bank Initiates Coverage on Roche With Buy Recommendation	06-21	MT
Nykredit Bank Starts Roche Coverage at Buy	06-21	MT
Sarepta Therapeutics Gets Expanded Label FDA Approval for Duchenne Muscular Dystrophy; Shares Soar Premarket	06-21	MT
Sarepta Therapeutics Gets Expanded US FDA Approval for Treatment of Duchenne Muscular Dystrophy; Shares Soar After Hours	06-20	MT
US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump	06-20	RE
Sarepta Shares Soar 37% Following Expanded Approval for Elevidys	06-20	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am